Evidence map›Paper›PMID 40845542›Full record

ArticleVaccine2025

Weaving a public health network: Process and results from an evaluation of CDC's Prevention Research Centers Vaccine Confidence Network.

Yulia E Chuvileva, Nicole M Kuiper, Aparna Ramakrishnan, Kenneth Goodman, Alyssa Jeffers, Hepsi Swarna, Pooja Gandhi, Melinda Reed-Morrice, Brigette Ulin

Abstract read
In one paragraph

Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yulia E ChuvilevaCenters for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Adolescent and School Health, 4770 Buford Hwy, Atlanta, GA 30341, USA. Electronic address: qna8@cdc.gov.
Nicole M KuiperCenters for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health, 4770 Buford Hwy, Atlanta, GA 30341, USA.
Aparna RamakrishnanDevi Partners, San Carlos, CA 94070, USA. Electronic address: aparna@devipartners.com.
Kenneth GoodmanKarna LLC, 2800 Century Pkwy Ste 700, Atlanta, GA 30345, USA. Electronic address: kgoodman@karna.com.
Alyssa JeffersCenters for Disease Control and Prevention, National Center for Infectious and Respiratory Diseases, Immunization Services Division, 1600 Clifton Rd. NE, Atlanta, GA 30333, USA. Electronic address: qcr5@cdc.gov.
Hepsi SwarnaKarna LLC, 2800 Century Pkwy Ste 700, Atlanta, GA 30345, USA. Electronic address: hswarna@karna.com.
Pooja GandhiKarna LLC, 2800 Century Pkwy Ste 700, Atlanta, GA 30345, USA. Electronic address: pgandhi@karna.com.
Melinda Reed-MorriceCenters for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Adolescent and School Health, 4770 Buford Hwy, Atlanta, GA 30341, USA.
Brigette UlinCenters for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health, 4770 Buford Hwy, Atlanta, GA 30341, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

As part of its COVID-19 pandemic response, in April 2021, the Centers for Disease Control and Prevention (CDC) funded 26 university-based Prevention Research Centers (PRCs) with a one-year award to raise vaccine confidence, demand, and uptake in diverse communities. The PRCs formed the Vaccine Confidence Network (VCN) to share information, resources, and strategies, and to collaborate. To support the VCN, CDC organized and facilitated numerous network activities, including hosting 14 virtual network meetings, a Slack channel, a resource library, and 4 office hours, disseminating 52 editions of a newsletter, and responding to 172 technical assistance requests from PRCs. These efforts aimed to increase meaningful and impactful collaborations over time so that PRCs' work benefited from their engagement in the VCN. We evaluated the VCN using two network surveys, an interim one at 6 months and a final one at 16 months, with 26 key informant interviews conducted during interim reporting to guide final survey tool development. The interim survey asked PRCs to report on the levels of collaboration and impact in their PRC-PRC relationships. The final survey repeated the interim survey's measurement and asked PRCs about the types of collaborations they engaged in with other PRCs, the types of impacts those collaborations had on their work, and how the collaborations came about (their origins). The number of reported undirected connections between the 26 PRCs grew by 72 %, from 53 to 91 between interim and final measurements. The self-reported amounts of collaboration and impact increased over time. The most common type of collaboration was exchange of information, tools, and resources (in 64/91, 70 % of undirected connections). While the most common type of impact was improved design (in 57/118, 48 % of directed connections). Of collaborations whose origins PRCs reported, 86 % (67/78) first connected during a VCN network activity, like chatting in a meeting or in Slack. The VCN example (i.e., its network practices and evaluation) could be useful to funders and self-organizing networks that are looking to enact coordinated responses to emergency and non-emergency public health and other issues.

Indexed as

COVID-19COVID-19 VaccinesPublic HealthCenters for Disease Control and Prevention, U.S.HumansSARS-CoV-2Surveys and QuestionnairesUnited StatesCOVID-19 VaccinesCollective impactCOVID-19 pandemicNetwork evaluationSocial network analysis

Identifiers

PMID40845542
PMCPMC12403165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.